BLU-667

Item number	Size	Manual	Delivery time	Price
LKT-B465806.1	1 mg	-	3 - 8 business days*	143.00€
LKT-B465806.5	5 mg	-	3 - 8 business days*	400.00€
LKT-B465806.25	25 mg	-	3 - 8 business days*	1,273.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

BLU-667 is an inhibitor of the rearranged during transfection (RET) kinase. RET is an oncogenic... more

Close menu

Product information "BLU-667"

BLU-667 is an inhibitor of the rearranged during transfection (RET) kinase. RET is an oncogenic driver activated in multiple cancers. BLU-667 is an early selective small molecule designed to target RET, in contrast with current treatment methods that have been limited to multikinase inhibitors. BLU-667 potently inhibits growth of RET-driven non-small cell lung cancer and thyroid cancer xenografts in vtiro. SMILES: Cc1[nH]nc(c1)Nc2nc(nc(c2)C)[C@H]3CC[C@@](CC3)(OC)C(=O)N[C@H](c4cnc(cc4)n5ncc(c5)F)C

Keywords:	BLU 667, BLU667, Pralsetinib, trans-N-{(1S)-1-[6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl}-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl}cyclohexanecarboxamide
Supplier:	LKT Laboratories
Supplier-Nr:	B465806

Properties

Application:	RET inhibitor
MW:	533.61 D
Formula:	C27H32FN9O2
Purity:	>98%

Database Information

CAS :	2097132-94-8\| Matching products
KEGG ID :	K05126 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +20°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

View product citations for antibody B465806 on CiteAb

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BLU-667"

Write a review